Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	25,716	11,334	12,497	17,432	17,116	19,426
Market Cap Growth	89.03%	-9.30%	-28.31%	1.85%	-11.89%	-
Enterprise Value	33,727	21,332	21,132	27,333	26,687	28,409
Last Close Price	44.65	24.88	26.57	36.44	36.09	44.60
PE Ratio	25.49	13.20	11.01	407.00	27.62	39.23
Forward PE	8.85	6.10	7.47	10.32	13.00	19.16
PS Ratio	8.25	5.01	5.31	7.79	7.48	9.15
PB Ratio	2.99	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	4.69	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	10.69	4.09	4.18	8.13	8.48	9.55
PEG Ratio	0.85	2.14	2.65	0.94	1.12	1.97
EV/Sales Ratio	14.35	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	21.59	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.93	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	3.47	1.43	7.78	2.11	16.77	8.73
Current Ratio	3.48	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	13.11%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	5.22%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital Employed (ROCE)	8.30%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	2.97%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.11%	3.38%	3.01%	2.08%	1.88%	0.67%
Payout Ratio	51.09%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	3.98%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	6.09%	4.83%	-34.65%	-3.50%	-8.60%	0.67%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q